Functional impact of sequence variation in the promoter region of TGFB1

被引:19
作者
Healy, Jasmine [1 ]
Dionne, Joelle [1 ]
Belanger, Helene [1 ]
Lariviere, Mathieu [1 ]
Beaulieu, Patrick [1 ]
Labuda, Damian [1 ,2 ]
Sinnett, Daniel [1 ,2 ]
机构
[1] Hop St Justine, Res Ctr, Div Hematol Oncol, Montreal, PQ H3T 1C5, Canada
[2] Univ Montreal, Dept Pediat, Fac Med, Montreal, PQ H3C 3J7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
promoter SNP; TGFB1; functional validation; gene expression; EMSA; TRANSFORMING-GROWTH-FACTOR; FACTOR-BETA; BREAST-CANCER; C-MYC; GENE; ASSOCIATION; RISK; POLYMORPHISMS; TGF-BETA-1; JAPANESE;
D O I
10.1002/ijc.24526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pathological deregulation of the transforming growth factor, beta 1 (TGFB1) pathway has been implicated in the development of several major diseases, including cancers. Regulatory variation in the TGFB1 gene may lead to altered TGFB1 expression and activity, and thus, modulate an individual's susceptibility to disease. Here, we performed a study of the functional relevance of cis-acting regulatory variation in the proximal promoter region of the TGFB1 gene. In a previous study, 9 promoter polymorphisms were identified in the 2kb region upstream of the transcription start site and 9 distinct promoter haplotypes were inferred from a panel of individuals from 5 distinct continental population groups. Following experimental validation, we found that the 2 major haplotypes significantly influenced TGFB1 transcriptional activity in an allele-specific manner and that 3 of the SNPs (-1886G>A, -509C>T and -1550DEL/AGG) altered DNA-protein complexe formation. Though the biological relevance of these findings remains to be verified, our study suggests that polymorphisms in the TGFB1 promoter could indeed influence gene expression and potentially contribute to the pathogenesis of TGFB1 related diseases. (C) 2009 UICC
引用
收藏
页码:1483 / 1489
页数:7
相关论文
共 30 条
[1]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[2]   Functional promoter SNPs in cell cycle checkpoint genes [J].
Bélanger, H ;
Beaulieu, P ;
Moreau, C ;
Labuda, D ;
Hudson, TJ ;
Sinnett, D .
HUMAN MOLECULAR GENETICS, 2005, 14 (18) :2641-2648
[3]   MAZ, A ZINC FINGER PROTEIN, BINDS TO C-MYC AND C2 GENE-SEQUENCES REGULATING TRANSCRIPTIONAL INITIATION AND TERMINATION [J].
BOSSONE, SA ;
ASSELIN, C ;
PATEL, AJ ;
MARCU, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7452-7456
[4]   Matlnspector and beyond: promoter analysis based on transcription factor binding sites [J].
Cartharius, K ;
Frech, K ;
Grote, K ;
Klocke, B ;
Haltmeier, M ;
Klingenhoff, A ;
Frisch, M ;
Bayerlein, M ;
Werner, T .
BIOINFORMATICS, 2005, 21 (13) :2933-2942
[5]   Transforming growth factor-β1-509T reduces risk of colorectal cancer, but not adenoma in Koreans [J].
Chung, Su J. ;
Kim, Joo S. ;
Jung, Hyun C. ;
Song, In S. .
CANCER SCIENCE, 2007, 98 (03) :401-404
[6]   TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study [J].
Cox, David G. ;
Penney, Kathryn ;
Guo, Qun ;
Hankinson, Susan E. ;
Hunter, David J. .
BMC CANCER, 2007, 7 (1)
[7]   Role of transforming growth factor-β signaling in cancer [J].
de Caestecker, MP ;
Piek, E ;
Roberts, AB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) :1388-1402
[8]  
Dunning AM, 2003, CANCER RES, V63, P2610
[9]   Role of transforming growth factor beta in human cancer [J].
Elliott, RL ;
Blobe, GC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :2078-2093
[10]  
Ewart-Toland A, 2004, CANCER EPIDEM BIOMAR, V13, P759